Pathogenic role of antimyeloperoxidase antibodies

被引:5
|
作者
Guilpain, P. [1 ,2 ]
Maldini, C. [1 ]
Guillevin, L. [1 ]
机构
[1] Univ Paris 05, Hop Cochin, AP HP, Fac Med,Ctr Natl Reference Malad Autoimmunes & Sy, F-75679 Paris 14, France
[2] Univ Paris 05, Hop Cochin, AP HP, Fac Med,EA 1833,IFR Alfred Jost,Lab Immunol, F-75014 Paris, France
来源
REVUE DE MEDECINE INTERNE | 2011年 / 32卷 / 07期
关键词
Antineutrophil cytoplasm antibodies; Anca; Myeloperoxidase; Vasculitis; Hypochlorous acid; Neutrophil; ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; SMALL-VESSEL VASCULITIS; MPO-ANCA; MICROSCOPIC POLYANGIITIS; MYELOPEROXIDASE; GLOMERULONEPHRITIS; NEUTROPHILS; PROPYLTHIOURACIL; INHIBITION; CELLS;
D O I
10.1016/j.revmed.2010.05.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antirnyeloperoxidase antibodies are a variety of antineutrophil cytoplasm antibodies (Anca), which can be detected in systemic small-sized vessel vasculitides such as microscopic polyangiitis, Wegener's granulomatosis and Churg-Strauss syndrome. Antimyeloperoxidase antibodies have been also associated with the development of lung fibrosis. Their pathogenic role has been well established, both in vitro and in vivo. These autoantibodies can activate neutrophils and trigger their oxidative burst leading to the release of free oxygen species and cytotoxic proteins. The oxidative burst is deleterious for the endothelium. Another mechanism by which antimyeloperoxidase may act is the activation of myeloperoxydase leading to an increased production of hypochlorous acid, which is highly toxic for the endothelial cells. These mechanisms contribute to the development of vasculitis. (C) 2010 Societe nationale francaise de medecine interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:411 / 415
页数:5
相关论文
共 50 条
  • [1] Pathogenic effects of antimyeloperoxidase antibodies in patients with microscopic polyangiitis
    Guilpain, Philippe
    Servettaz, Amelie
    Goulvestre, Claire
    Barrieu, Sandrine
    Borderie, Didier
    Chereau, Christiane
    Kavian, Niloufar
    Pagnoux, Christian
    Guillevin, Loic
    Weill, Bernard
    Mouthon, Luc
    Batteux, Frederic
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (07): : 2455 - 2463
  • [2] SILICOSIS, ANTIMYELOPEROXIDASE ANTIBODIES AND GLOMERULOPATHY
    TALASZKA, A
    BOULANGER, E
    LEMONIES, H
    [J]. NEPHROLOGIE, 1992, 13 (05): : 234 - 234
  • [3] ANTIMYELOPEROXIDASE ANTIBODIES IN CRESCENTIC GLOMERULONEPHRITIS
    BOSCH, X
    MIRAPEIX, E
    FONT, J
    INGELMO, M
    REVERT, L
    [J]. NEPHRON, 1991, 59 (03): : 504 - 505
  • [4] ANTIMYELOPEROXIDASE ANTIBODIES AND CLINICAL ASSOCIATIONS
    DAHA, MR
    FALK, RJ
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 1990, 36 (3-4): : 152 - 153
  • [5] ANTIMYELOPEROXIDASE ANTIBODIES IN PATIENTS WITH EXTRACAPILLARY GLOMERULONEPHRITIS
    NASSBERGER, L
    SJOHOLM, AG
    THYSELL, H
    [J]. NEPHRON, 1990, 56 (02): : 152 - 156
  • [6] Pathogenic role of antiphospholipid antibodies
    Salmon, J. E.
    de Groot, P. G.
    [J]. LUPUS, 2008, 17 (05) : 405 - 411
  • [7] ANTIMYELOPEROXIDASE ANTIBODIES AND ADVERSE REACTIONS TO CLOZAPINE
    JAUNKALNS, R
    SHEAR, NH
    SOKOLUK, B
    GARDNER, D
    CLAAS, F
    UETRECHT, JP
    [J]. LANCET, 1992, 339 (8809): : 1611 - 1612
  • [8] ANTIMYELOPEROXIDASE ANTIBODIES - ACTIVITY MARKER ON VASCULITIS
    ALBA, D
    TORRES, E
    MOLINA, F
    OLMO, A
    [J]. REVISTA CLINICA ESPANOLA, 1992, 191 (08): : 453 - 453
  • [9] ANTIMYELOPEROXIDASE ANTIBODIES - IMMUNOLOGICAL CHARACTERISTICS AND CLINICAL ASSOCIATIONS
    GUEIRARD, P
    DELPECH, A
    GILBERT, D
    GODIN, M
    LELOET, X
    TRON, F
    [J]. JOURNAL OF AUTOIMMUNITY, 1991, 4 (03) : 517 - 527
  • [10] CHARACTERIZATION OF ANTIMYELOPEROXIDASE (MPO) ANTIBODIES (ABS) IN VASCULITIS
    TADROS, M
    POZZI, C
    RADICE, A
    SINICO, RA
    DAMICO, G
    [J]. KIDNEY INTERNATIONAL, 1993, 43 (03) : 763 - 763